Closed · RFA-DP-24-081 · CFDA 93.068 · Discretionary
Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- up to $950K
- Award range
- Closed
- Status
- March 22, 2024
- Close date
- 5
- Expected awards
The verdict
Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $950,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number.
- up to $950K
- award range
- Closed
- application status
- 5
- expected awards
- 93.068
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings - is cataloged under number RFA-DP-24-081 and tied to CFDA assistance listing 93.068, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on November 28, 2023 and last updated on February 21, 2024. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Up to $950,000. The agency has projected $15.0 million in total estimated funding for this announcement. It expects to issue 5 awards. If the agency funds the expected 5 awards from the $15.0 million estimated pool, the average award works out to roughly $3.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on March 22, 2024. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $950,000
Close Date
March 22, 2024
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
November 28, 2023
Est. Total Funding
$15,000,000
Expected Awards
5
Instrument
Cooperative Agreement
Description
Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 - 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION - The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 20, 22, 23, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Alison Amoroso, Scientific Program Official uxl8@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
RFA-IP-18-000
RFA-CC-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |